STEWART; Mark Richard

Patent Applications and Registrations

Patent applications and USPTO patent grants for STEWART; Mark Richard.The latest application filed is for "factor xiia inhibitors".

Company Profile

4.8.12

STEWART; Mark Richard - Saffron Walden GB
STEWART; Mark Richard - Cambridge GB
STEWART; Mark Richard - Saffron Walden Essex GB
Stewart; Mark Richard - Cambridgeshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Factor Xiia Inhibitors App 20220305011 - PHILIPPOU; Helen ; et al.	2022-09-29
Compounds And Methods For The Treatment Of Ocular Disorders App 20210230205 - HOLMES; Ian ; et al.	2021-07-29
5-(pyrimidin-4-yl)-2-(pyrrolidin-1-yl)nicotinonitrile compounds as IKKE, TBK1 and/or SIK2 kinases inhibitors Grant 11,058,686 - Newton , et al. July 13, 2	2021-07-13
Compounds And Methods For The Treatment Of Ocular Disorders App 20210107899 - HOLMES; Ian ; et al.	2021-04-15
FACTOR XIIa INHIBITORS App 20210087172 - PHILIPPOU; Helen ; et al.	2021-03-25
Compounds and methods for the treatment of ocular disorders Grant 10,875,845 - Holmes , et al. December 29, 2	2020-12-29
Compounds And Methods For The Treatment Of Ocular Disorders App 20200331896 - HOLMES; Ian ; et al.	2020-10-22
5-(pyrimidin-4-yl)-2-(pyrrolidin-1-yl)nicotinonitrile Compounds As Ikke, Tbk1 And/or Sik2 Kinases Inhibitors App 20200030326 - NEWTON; Gary Karl ; et al.	2020-01-30
Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms Grant 9,433,622 - Newton , et al. September 6, 2	2016-09-06
Pyrimidine Compounds Useful In The Treatment Of Diseases Mediated By Ikke And/or Tbk1 Mechanisms App 20160000784 - Newton; Gary Karl ; et al.	2016-01-07
Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them Grant 8,962,609 - Perrior , et al. February 24, 2	2015-02-24
Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use Grant 8,637,453 - Robinson , et al. January 28, 2	2014-01-28
Pyrimidine Compounds As Inhibitors Of Protein Kinases Ikk Epsilon And/or Tbk-1, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them App 20130267491 - Perrior; Trevor Robert ; et al.	2013-10-10
Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use Grant 8,541,363 - Robinson , et al. September 24, 2	2013-09-24
Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use App 20130217617 - Robinson; Clive ; et al.	2013-08-22
Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use App 20120322722 - Robinson; Clive ; et al.	2012-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.